Ignite Creation Date:
2025-12-24 @ 1:36 PM
Ignite Modification Date:
2025-12-30 @ 4:12 PM
Study NCT ID:
NCT00381095
Status:
TERMINATED
Last Update Posted:
2021-01-20
First Post:
2006-09-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study To Evaluate Pregabalin In The Treatment Of Moderate To Severe Chronic Bone Pain Related To Metastatic Cancer
Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-12
Start Date Type:
None
Primary Completion Date:
2010-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-10
Completion Date Type:
ACTUAL
First Submit Date:
2006-09-25
First Submit QC Date:
None
Study First Post Date:
2006-09-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-08-18
Results First Submit QC Date:
None
Results First Post Date:
2011-09-27
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-01-15
Last Update Post Date:
2021-01-20
Last Update Post Date Type:
ACTUAL